title: Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage.
abstract: In conclusion, disseminated strongyloidiasis is a fatal disease that commonly affects the lungs. The disease should be suspected in an immunocompromised host who came from an area endemic for S stercoralis even years before the onset of symptoms or in patients with unexplained gram-negative bacteremia or meningitis. Treatment should be started promptly and should be maintained for a long time.
authors.affiliation: Division of Pulmonary Diseases, Mount Sinai Medical Center, Miami Beach, Fla.
authors.forename: M R
authors.initials: MR
authors.lastname: Kramer
authors.forename: P A
authors.initials: PA
authors.lastname: Gregg
authors.forename: M
authors.initials: M
authors.lastname: Goldstein
authors.forename: R
authors.initials: R
authors.lastname: Llamas
authors.forename: B P
authors.initials: BP
authors.lastname: Krieger
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000469:parasitology*; D001996:Bronchopneumonia / Q000150:complications* / Q000276:immunology / Q000469:parasitology; D006801:Humans; D007108:Immune Tolerance; D007814:Larva / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013183:Sputum / Q000469:parasitology*; D013321:Strongyloides / Q000302:isolation & purification; D013322:Strongyloidiasis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013827:Thiabendazole / Q000627:therapeutic use
chemical_list: D013827:Thiabendazole